215D
CRYSTAL STRUCTURE OF FOUR MORPHOLINO-DOXORUBICIN ANTICANCER DRUGS COMPLEXED WITH D(CGTACG) AND D(CGATCG): IMPLICATIONS IN DRUG-DNA CROSSLINK
Functional Information from PDB Data
| site_id | 1 |
| Number of Residues | |
| Details |
| Chain | Residue |
| site_id | AC1 |
| Number of Residues | 15 |
| Details | BINDING SITE FOR RESIDUE DMM A 7 |
| Chain | Residue |
| A | DC1 |
| A | HOH15 |
| A | HOH17 |
| A | HOH23 |
| A | HOH27 |
| A | HOH28 |
| A | HOH53 |
| A | DG2 |
| A | DT3 |
| A | DA4 |
| A | DA4 |
| A | DC5 |
| A | DG6 |
| A | HOH11 |
| A | HOH13 |
